Thymalin side effects and risks

Reported side effects

• Allergic reactions: Russian instructions list allergy without a rate., serious. Stop the product; breathing trouble, swelling or fainting needs emergency care. (source)
• Headache reported online: One commenter asked about a migraine like headache; causation was not established., mild. A new severe or persistent headache needs assessment. (source)
• Irritability while stacked: One user reported mood swings while also taking Epitalon; later attribution was uncertain., moderate. Review all drugs and pause the suspected product if symptoms appear. (source)

Stop and get help if

• Trouble breathing, throat or face swelling, or collapse after injection: Stop and call emergency services now.
• Fever with shaking chills, confusion, or spreading redness after injection: Seek urgent care for possible serious infection or contaminated product.
• New chest pain, severe breathlessness, fainting or heavy bleeding: Seek emergency care now.

Who should avoid it

• pregnant: Russian instructions contraindicate use during pregnancy.
• breastfeeding: Russian instructions contraindicate use during breastfeeding.
• tryingToConceive: Precaution: reproductive safety is unestablished; pregnancy is contraindicated in the Russian instructions.
• under18: Historical pediatric reports do not establish safety for unsupervised use.
• other: Individual intolerance is a stated contraindication. The product is derived from cattle and contains glycine.
• autoimmuneDisease: It changes immune activity. Old autoimmune-disease reports do not establish safety across conditions.
• immunosuppressed: Immune effects may conflict with transplant or immune-suppressing care. Direct interaction studies are missing.
• activeCancer: Historical cancer adjunct reports do not establish safety with modern cancer therapy. Oncology review is needed.
• kidneyDisease: No validated dose adjustment; renal failure was excluded from the retrospective COVID-19 study.
• liverDisease: No validated dose adjustment; raised liver enzymes were excluded from that COVID-19 study.
• bleedingDisorder: Historical studies report changes in clotting and fibrinolysis; bleeding risk is not quantified.
• testedAthlete: Thymalin is not named on the 2026 list; the exact product needs an anti-doping ruling.

Interactions

• Immune-suppressing drugs: Possible opposing immune effects are theoretical. Historical co-use does not establish safety, especially after transplant.
• Anticoagulants and antiplatelet drugs: Clotting changes were observed; interaction and bleeding rates are unknown. Hospital heparin co-use is not proof of general safety.
• Other thymus immune peptides: Overlapping immune effects; no validated combined regimen. Similar names do not mean the same drug.

Product quality risks

• A vial containing a single synthetic peptide is not proven equivalent to the studied thymus extract.
• No independent peer-reviewed survey of online Thymalin identity, dose, sterility or endotoxin was located.
• Regulators report contamination, uncertain doses and serious reactions with unapproved peptides generally.
• General online semaglutide testing found quality failures; those results do not measure Thymalin failure rates.